Endorsements

The following individuals “share the goals of the Optimal Cancer Care Alliance and believe it is a clinical, financial, and ethical imperative to replace current oncology overdosing with optimal dosing. The right amount of medication at the right time reduces toxic side effects, provides the best clinical outcomes and lowers costs.”

First NameLast NameTitle/PositionInstitutional Affiliation
Dr.AjayAggarwalInstitute of Cancer Policy, King's College, London
Dr.AmolAkhadeNair Hospital, Mumbai
Dr. EitanAmirMedical OncologistPrincess Margaret Cancer Centre
Dr. DanielAraujoMedical OncologistHospital de Base, Sao Jose do Rio Preto
Dr.ZebaAzizProfessorHameed Latif Hospital, Lahore, Pakistan
Dr. RajendraBadweDirectorTata Memorial Centre
Dr. DavidBaerSenior OncologistKaiser Permanente
Dr. Robert (Bob)BellProfessor EmeritusUniversity of Toronto
Dr. ScottBerryProfessor and HeadDepartment of Oncology, Queen's University
Dr.ChrisBoothProfessor of OncologyQueen's University
Dr. GauthierBoucheThe Anticancer Fund
Dr.MarcBuyseChief Scientific DirectorIDDI
Dr. EmilianoCalvoDirector, Clinical ResearchSTART Madrid
Dr.KelvinChanMedical OncologistSunnybrook Cancer Centre
Dr.MarkClemonsMedical OncologistThe Ottawa Hospital
Dr. GiovanniCodacci-PisanelliResearch AssistantUniversity of Rome "la Sapienza" Roma Italy
Dr. PippaCorrieConsultant Medical OncologistCambridge University Hospitals NHS Foundation Trust
Dr.GiuseppeCuriglianoProfessorEuropean Institute of Oncology
Dr. SarahDansonProfessor of Medical OncologyUniversity of Sheffield, UK
Dr.GraceDyChief Thoracic Oncology MedicineRoswell Park Comprehensive Cancer Center
Dr. HelenaEarlProfessor EmeritusUniversity of Cambridge, Dept of Oncology
Dr.LexEggermontChief Scientific OfficerPrincess Maxima Center, Ultrecht University
Dr. MakotoEndoKyushu University Hospital
Dr.Doreen EzeifeMedical OncologistTom Baker Cancer Centre
Dr. DougFiggSenior InvestigatorNational Cancer Institute/NIH
Dr. VarshaGandhiProfessorMD Anderson Cancer Center
Dr. MarkGeraciNational PBM Clinical Pharmacy Program ManagerDept of Veterans Affairs
Dr.ErnestoGil DezaDirector of Education and ResearchInstituto Henry Moore
Dr.SilkeGillessonProfessorOncology Institute of Southern Switzerland
Dr. Boon-CherGohProfessorNational University Cancer Institute, Singapore
Dr. YasushiGotoNagasaki University Hospital
Dr.GwenaёlleGravis-MescamInstitut Paoli-Calmettes Marseille France
Dr. AlastairGreystokeSenior LecturerNewcastle University
Dr. ӦrvarGunnarssonMedical OncologyLandspitali, University Hospital, Iceland
Dr.BishalGyawaliAssociate ProfessorQueen's University
Dr.AllanHackshawProfessor, DirectorCancer Research UK & UCL Cancer Trials Centre
Dr.NazikHammadMedical OncologistQueens University
Dr.JohnHickman ProfessorUniversity of Manchester
Dr.IanHirschPrincess Margaret Cancer Centre
Dr.AnthonyJoshuaProfessorKinghorn Cancer Centre, St Vincents Hospital Sydney
Dr. MichaelKelleyProfessor of MedicineDuke University
Dr. Jonathon KimmelmanProfessorMcGill University / School of Population and Global Health
Dr. JennyKoMedical OncologistBC Cancer - Abbotsford
Dr. HideoKunitohJapanese Red Cross Medical Center
Dr. RuthLangleyProfessorMRC CTU at UCL
Dr. RayaLeibowitzHeadOncology Institute, Shamir Medical Center, Israel
Dr. LisaLicitraProfessorFondazione IRCCS Istituto Nazionale dei Tumori
Dr. AnneLoeserFounderPatient-Centered Dosing Initiative
Dr. HerbertLoongAssociate ProfessorThe Chinese University of Hong Kong
Dr. IndranilMallickSenior Consultant OncologistTata Medical Center, Kolkata
Dr. SarojNiraulaMedical OncologistCancer Care Manitoba
Dr. VanitaNoronhaProfessor of OncologyTata Memorial Centre
Dr. TakahiroOsawaHokkaido University
Dr. LeezaOsiepenkoCEO, DrConsilium Scientific
Dr. MaxParmarProfessorUCL
Dr. AmolPatelAssociate ProfessorINHS ASVINI
Dr.CodyPeerClinical PharmacologistNational Cancer Institute
Dr.FrancoPerroneDirector Clinical Trial UnitNCI, Naples Italy
Dr. MartinePiccartScientific Director, Institut Jules Bordet
Dr. RuthPlummerProfessor of Experimental Cancer MedicineNewcastle University, UK
Dr. GregoryPondAssociate ProfessorMcMaster University
Dr. AtikRahmanDirector, DCPIIFDA
Dr. RachelRiechelmannA.C Camargo Cancer Center
Dr. GaryRosnerProfessor EmeritusJohns Hopkins
Dr. EverardoSaadMedical DirectorIDDI
Dr. RobbeSaesenResearch FellowEORTC
Dr. TetsuoSaitoArao Municipal Hospital
Dr. MartinSchoenAssistant Professor St Louis University
Dr. PeterSelbyEmeritus ProfessorUniversity of Leeds
Dr. ManjuSengarProfessorTata Memorial Centre
Dr. LesleySeymourDirector, IND Program, Deputy Director, CCTG, Professor, Queens University
Dr. MattSeymourProfessor of Cancer MedicineUniversity of Leeds
Dr. LillianSiuMedical OncologistPrincess Margaret Cancer Centre
Dr.GabeSonkeProfessorNetherlands Cancer Institute
Dr. WalterStadlerProfessor of MedicineUniversity of Chicago
Dr. AnastasiosStathisHead-New Drugs Development Unit
Chair-Clinical Research
Oncology Institute of Southern Switzerland-IOSI
Dr. MartinStocklerProfessor of Oncology and Clinical EpidemiologyNHRMC Clinical Trials Centre, University of Sydney
Dr. RichardSullivanProfessorInstitute of Cancer Policy
Dr. ChrisSweeneyProfessor, Director SAiGENCI – South Australian immunoGENomics Cancer InstituteThe University of Adelaide
Dr. ShinnosukeTakemotoNagasaki University Hospital
Dr. Winette van der GraafProfessorNetherlands Cancer Institute
Dr. Roger von MoosProfessorMedical Oncology, Cantonal Hospital Graubϋnden, Switzerland
Dr. Jonathan WadsleyProfessorWeston Park Cancer Centre, Sheffield UK
Dr. Lori WoodMedical OncologistQueen Elizabeth II Health Sciences Centre
Dr. JohnZalcbergProfessorMonash University

(Institutional affiliations are listed for identification purposes only)